The regulation of acetyl-CoA carboxylase - A potential target for the action of hypolipidemic agents

Advances in Enzyme Regulation

Volumn 39, Issue 1, 1999, Pages 205-234

  Munday, Michael R ^a   Hemingway, Cheryl J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(HYDROXYMETHYLGLUTARYL-COA REDUCTASE (NADPH)) KINASE; ACETYL COENZYME A CARBOXYLASE; ANTILIPEMIC AGENT; BEZAFIBRATE; CLOFIBRATE; CLOFIBRIC ACID; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; MULTIENZYME COMPLEX; PROTEIN SERINE THREONINE KINASE;

ALLOSTERISM; AMINO ACID SEQUENCE; ANIMAL; BINDING SITE; CHEMISTRY; CONFERENCE PAPER; DRUG MECHANISM; DRUG TARGETING; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; HYPERLIPIDEMIA; METABOLISM; MOLECULAR GENETICS; NONHUMAN; PHOSPHORYLATION; RAT;

EID: 0032878549     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(98)00016-8     Document Type: Conference Paper

References (158)

1. D. G. HARDIE, Regulation of fatty acid synthesis via phosphorylation of acetyl-CoA carboxylase, Prog. Lipid Res. 28, 117-146 (1989).
2. J. D. MCGARRY and N. F. BROWN, The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis, Eur. J. Biochem. 244, 1-14 (1997).
3. M. J. H. GEELEN, R. A. HARRIS, A. C. BEYNEN and S. A. MCCUNE, Short-term hormonal control of hepatic lipogenesis, Diabetes 29, 1006-1022 (1980).
4. R. B. GUCHHAIT, S. E. POLAKIS, P. DIMROTH, E. STOLL, J. MOSS and M. D. LANE, Acetyl-CoA carboxylase system of Escherichia coli, J. Biol. Chem. 249, 6633-6645 (1974).
5. F. AHMAD, P. M. AHMAD, L. PIERETTI and G. T. WATTERS, Purification and subunit structure of rat mammary gland acetyl-CoA carboxylase, J. Biol. Chem. 253, 1733-1737 (1978).
6. K. G. THAMPY, Formation of malonyl coenzyme A in rat heart, J. Biol. Chem. 264, 17631-17634 (1989).
7. R. WINZ, D. HESS, R. AEBERSOLD and R. W. BROWNSEY, Unique structural features and differential phosphorylation of the 280 kDa component of rat liver acetyl-CoA carboxylase, J. Biol. Chem. 269, 14438-14445 (1994).
8. G. E. TRUMBLE, M. A. SMITH and W. W. WINDER, Purification and characterisation of rat skeletal muscle acetyl-CoA carboxylase, Eur. J. Biochem. 231, 192-198 (1995).
9. A. BIANCHI, J. L. EVANS, A. J. IVERSON, A-C. NORDLUND, T. D. WATTS and L. A. WITTERS, Identification of an isozymic form of acetyl-CoA carboxylase, J. Biol. Chem. 265, 1502-1509 (1990).
10. F. LOPEZ-CASILLAS, D-H. BAI, X. LUO, I-S. KONG, M. HERMODSON and K-H. KIM, Structure of the coding sequence and primary amino acid sequence of acetylcoenzyme A carboxylase, Proc. Natl. Acad. Sci. USA 85, 5784-5788 (1988).
11. L. ABU-ELHEIGA, A. JAYAKUMAR, A. BALDINI, S. S. CHIRALA and S. J. WAKIL, Human acetyl-CoA carboxylase: characterisation, molecular cloning, and evidence for two isoforms, Proc. Natl. Acad. Sci. USA 92, 4011-4015 (1995).
12. J. HA, J-K. LEE, K-S. KIM, L. A. WITTERS and K-H. KIM, Cloning of human acetyl-CoA carboxylase-β and its unique features, Proc. Natl. Acad. Sci. USA 91, 11466-11470 (1996).
13. J. WIDMER, K. S. FASSIHI, S. C. SCHLICHTER, K. S. WHEELER, B. E. CRUTE, N. KING, N. NUTILE-MCMENEMY, W. W. KNOLL, S. DANIEL, J. HA, K-H. KIM and L. A. WITTERS, Identification of a second human acetyl-CoA carboxylase gene, Biochem. J. 316, 915-922 (1996).
14. L. ABU-ELHEIGA, D. B. ALMARZA-ORTEGA, A. BALDINI and S. J. WAKIL, Human acetyl-CoA carboxylase 2, J. Biol. Chem. 272, 10669-10677 (1997).
15. M. R. MUNDAY, D. G. CAMPBELL, D. CARLING and D. G. HARDIE, Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase, Eur. J. Biochem. 175, 331-338 (1988).
16. K.-H. KIM, Regulation of mammalian acetyl-Coenzyme A carboxylase, Annu. Rev. Nutr. 17, 77-99 (1997).
17. J. B. ALLRED and C. R. ROMAN-LOPEZ, Enzymatically inactive forms of acetyl-CoA carboxylase in rat liver mitochondria, Biochem. J. 251, 881-885 (1988).
18. A. J. IVERSON, A. BIANCHI, A-C. NORDLUND and L. A. WITTERS, Immunological analysis of acetyl-CoA carboxylase mass, tissue distribution and subunit composition, Biochem. J. 269, 365-371 (1990).
19. M. J. H. GEELEN, C. BIJLEVELD, G. VELASCO, R. J. A. WANDERS and M. GUZMAN, Studies on the intracellular localisation of acetyl-CoA carboxylase, Biochem. Biophys. Res. Comm. 233, 253-257 (1997).
20. J. M. KIM, M. YOON, I. KANG, S. S. KIM and J. HA, Evidence that acetyl-CoA carboxylase isoforms play different biological roles in H9c2 cardiomyocyte, Biochem. Biophys. Res. Comm. 248, 490-496 (1998).
21. B. A. ASHCRAFT, W. S. FILLERS, S. L. AUGUSTINE and S. D. CLARKE, Polymer-protomer transition of acetyl-CoA carboxylase occurs in vivo and varies with nutritional conditions, J. Biol. Chem. 255, 10033-10035 (1980).
22. A. C. BORTHWICK, N. J. EDGELL and R. M. DENTON, Use of rapid gel-permeation chromatography to explore the inter-relationships between polymerisation, phosphorylation and activity of acetyl-CoA carboxylase, Biochem. J. 241, 773-782 (1987).
23. K. G. THAMPY and S. J. WAKIL, Regulation of ACC. Effect of fasting and refeeding on reactivity, phosphate content and aggregation state of the enzyme, J. Biol. Chem. 263, 6454-6458 (1988).
24. S. NAKANISHI and S. NUMA, Purification of rat liver acetyl coenzyme A carboxylase and immunochemical studies on its synthesis and degradation, Eur. J. Biochem. 16, 161-173 (1970).
25. N. IRITANI, Nutritional and hormonal regulation of lipogenic-enzyme gene expression in rat liver, Eur. J. Biochem. 205, 433-442 (1992).
26. J. C. MACKALL and M. D. LANE, Changes in mammary gland acetyl-coenzyme A carboxylase associated with lactogenic differentiation, Biochem. J. 162, 635-642 (1977).
27. M. E. PAPE, F. LOPEZ-CASILLAS and K-H. KIM, Physiological regulation of acetyl-CoA carboxylase gene expression. Effects of diet, diabetes, and lactation on acetyl-CoA carboxylase mRNA, Arch. Biochem. Biophys. 267, 104-109 (1988).
28. M. C. BARBER, M. T. TRAVERS, E. FINLEY, D. FLINT and R. VERNON, Growth hormone-prolactin interactions in the regulation of mammary and adipose- tissue acetyl-CoA carboxylase activity and gene expression in lactating rats, Biochem. J. 285, 469-475 (1992).
29. F. FOUFELLE, D. PERDEREAU, B. GOUHOT, P. FERRE and J. GIRARD, Effects of diets rich in medium-chain and long-chain triglycerides on lipogenic-enzyme gene expression in liver and adipose tissue of the weaned rat, Eur. J. Biochem. 208, 381-387 (1992).
30. F. FOUFELLE, J. GIRARD and P. FERRE, Regulation of lipogenic enzyme expression by glucose in liver and adipose tissue: a review of the potential cellular and molecular mechanisms, Advan. Enzyme Regul. 36, 199-227 (1996).
31. T. BRUN, E. ROCHE, K-H. KIM and M. PRENTKI, Glucose regulates acetyl-CoA carboxylase gene expression in a pancreatic β-cell line (INS-1), J. Biol. Chem. 268, 18905-18911 (1993).
32. M. R. MUNDAY, M. R. MILIC, S. TAKHAR, M. J. HOLNESS and M. C. SUGDEN, The short-term regulation of hepatic acetyl-CoA carboxylase during starvation and refeeding in the rat, Biochem. J. 280, 733-737 (1991).
33. K. NISHIKORI, N. IRITANI and S. NUMA, Levels of acetyl coenzyme A carboxylase and its effectors in rat liver after short-term fat-free refeeding, FEBS Letters 32, 19-21 (1973).
34. A. KATSURADA, N. IRITANI, H. FUKUDA, Y. MATSUMURA, N. NISHIMOTO, T. NOGUCHI and T. TANAKA, Effects of nutrients and hormones on transcriptional regulation of acetyl-CoA carboxylase in rat liver, Eur. J. Biochem. 190, 435-441 (1990).
35. N. IRITANI, N. NISHIMOTO, A. KATSURADA and H. FUKUDA, Regulation of hepatic lipogenic enzyme gene expression by diet quantity in rats fed a fat-free, high carbohydrate diet, J. Nutr. 122, 28-36 (1992).
36. S. P. DAVIES, D. CARLING, M. R. MUNDAY and D. G. HARDIE, Diurnal rhythm of phosphorylation of rat liver acetyl-CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping. Effects of high fat diets, Eur. J. Biochem. 203, 615-623 (1992).
37. M. J. TOUSSANT, M. D. WILSON and S. D. CLARKE, Coordinate suppression of liver acetyl-CoA carboxylase and fatty acid synthetase by polyunsaturated fat, J. Nutr. 111, 146-153 (1981).
38. F. LOPEZ-CASILLAS, M. V. PONCE-CASTANEDA and K-H. KIM, In vivo regulation of the activity of the two promoters of the rat acetyl-CoA carboxylase gene, Endocrinology 129, 1049-1058 (1991).
39. H. J. TAE, X. LUO and K-H. KIM, Roles of CCAAT/enhancer binding protein and its binding site on repression and derepression of acetyl-CoA carboxylase gene, J. Biol. Chem. 269, 10475-10484 (1994).
40. S. DANIEL, S. ZHANG, A. A. DEPAOLI-ROACH and K-H. KIM, Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene, J. Biol. Chem. 271, 14692-14697 (1996).
41. D. G. HARDIE and P. S. GUY, Reversible phosphorylation and inactivation of acetyl-CoA carboxylase from lactating rat mammary gland by cyclic AMP-dependent protein kinase, Eur. J. Biochem. 110, 167-177 (1980).
42. E. STOLL, E. RYDER, J. B. EDWARDS and M. D. LANE, Liver acetyl coenzyme A carboxylase: activation of model partial reactions by tricarboxylic acids, Proc. Natl. Acad. Sci. USA 60, 986-991 (1968).
43. T. HASHIMOTO and S. NUMA, Kinetic studies on the reaction mechanism and the citrate activation of liver acetyl coenzyme A carboxylase, Eur. J. Biochem. 18, 319-331 (1971).
44. A. P. HALESTRAP and R. M. DENTON, Hormonal regulation of adipose-tissue acetyl-coenzyme A carboxylase by changes in the polymeric state of the enzyme, Biochem. J. 142, 365-377 (1974).
45. K. HAGOPIAN and M. R. MUNDAY, The role of pyruvate dehydrogenase, phosphofructo-1-kinase and acetyl-CoA carboxylase in the regulation of fatty acid synthesis in the lactating rat mammary gland during the starved to refed transition, Biochim. Biophys. Acta 1336, 474-484 (1997).
46. N. B. BEATY and M. D. LANE, Kinetics of activation of acetyl-CoA carboxylase by citrate. Relationship to the rate of polymerization of the enzyme, J. Biol. Chem. 258, 13043-13050 (1983).
47. M. J. MEREDITH and M. D. LANE, Acetyl-CoA carboxylase. Evidence for polymeric filament to protomer transition in the intact avian liver cell, J. Biol. Chem. 253, 3381-3383 (1978).
48. K. G. THAMPY and S. J. WAKIL, Regulation of acetyl-coenzyme A carboxylase. Purification and properties of two forms of acetyl-coenzyme A carboxylase from rat liver, J. Biol. Chem. 263, 6447-6453 (1988).
49. J. NIKAWA, T. TANABE, H. OGIWARA, T. SHIBA and S. NUMA, Inhibitory effects of long-chain acyl coenzyme A analogues on rat liver acetyl coenzyme A carboxylase, FEBS Letters 102, 223-226 (1979).
50. N. J. FAERGEMAN and J. KNUDSEN, Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling, Biochem. J. 323, 1-12 (1997).
51. P. A. MAYES and D. L. TOPPING, Regulation of hepatic lipogenesis by plasma free fatty acids: simultaneous studies on lipoprotein secretion, cholesterol synthesis, ketogenesis and gluconeogenesis, Biochem. J. 140, 111-114 (1974).
52. H. INOUE and J. M. LOWENSTEIN, Acetyl coenzyme A carboxylase from rat liver. Purification and demonstration of different subunits, J. Biol. Chem. 247, 4825-4832 (1972).
53. C. A. CARLSON and K-H. KIM, Regulation of hepatic acetyl coenzyme A carboxylase by phosphorylation and dephosphorylation, J. Biol. Chem. 248, 378-380 (1973).
54. M. R. MUNDAY and D. G. HARDIE, The role of acetyl-CoA carboxylase phosphorylation in the control of mammary gland fatty acid synthesis during the starvation and re-feeding of lactating rats, Biochem. J. 237, 85-91 (1986).
55. G. M. MABROUK, I. M. HELMY, K. G. THAMPY and S. J. WAKIL, Acute hormonal control of acetyl-CoA carboxylase. The roles of insulin, glucagon and epinephrine, J. Biol. Chem. 265, 6330-6338 (1990).
56. T. A. HAYSTEAD, D. G. CAMPBELL and D. G. HARDIE, Analysis of sites phosphorylated on acetyl-CoA carboxylase in response to insulin in isolated adipocytes. Comparison with sites phosphorylated by casein kinase 2 and calmodulin-dependent multiprotein kinase, Eur. J. Biochem. 175, 347-354 (1988).
57. S. P. DAVIES, A. T. R. SIM and D. G. HARDIE, Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase, Eur J. Biochem. 187, 183-190 (1990).
58. J. HA, S. DANIEL, S. S. BROYLES and K-H. KIM, Critical phosphorylation sites for acetyl-CoA carboxylase activity, J. Biol. Chem. 269, 22162-22168 (1994).
59. M. R. MUNDAY, D. CARLING and D. G. HARDIE, Negative interactions between phosphorylation of acetyl-CoA carboxylase by the cyclic AMP-dependent and AMP-activated protein kinases, FEBS Letters 235, 144-148 (1988).
60. T. S. INGEBRITSEN, J. BLAIR, P. GUY, L. WITTERS and D. G. HARDIE, The protein phosphatases involved in cellular regulation. Fatty acid synthesis, cholesterol synthesis and glycolysis/gluconeogenesis, Eur. J. Biochem. 132, 275-281 (1983).
61. T. A. J. HAYSTEAD, A. T. R. SIM, D. CARLING, R. C. HONNOR, Y. TSUKITANI, P. COHEN and D. G. HARDIE, Effects of the tumour-promoter okadaic acid on intracellular protein phosphorylation and metabolism, Nature 337, 78-81 (1989).
62. G. A. RUTTER, A. C. BORTHWICK and R. M. DENTON, Effects of protein phosphatase inhibitors on the regulation of insulin-sensitive enzymes within rat epididymal fat pads and cells, Biochem. J. 276, 649-654 (1991).
63. V. GAUSSIN, P. SKARLAS, Y. P. CHING, D. G. HARDIE and L. HUE, Distinct type-2A protein phosphatases activate HMG-CoA reductase and acetyl-CoA carboxylase in liver, FEBS Letters 413, 115-118 (1997).
64. M. R. MUNDAY and D. G. HARDIE, The role of protein phosphorylation in the regulation of fatty acid synthesis in the mammary gland of the lactating rat, pp. 563-613 in The Mammary Gland: Development, Regulation and Function (M. C. NEVILLE and C. DANIEL, eds.), Plenum Press, New York (1987).
65. L. A. WITTERS, E. M. KOWALOFF and J. AVRUCH, Glucagon regulation of protein phosphorylation. Identification of acetyl coenzyme A carboxylase as a substrate, J. Biol. Chem. 254, 245-248 (1979).
66. R. HOLLAND, L. A. WITTERS and D. G. HARDIE, Glucagon inhibits fatty acid synthesis in isolated hepatocytes via phosphorylation of acetyl-CoA carboxylase by cyclic-AMP-dependent protein kinase, Eur. J. Biochem. 140, 325-333 (1984).
67. R. W. BROWNSEY, W. A. HUGHES and R. M. DENTON, Adrenaline and the regulation of acetyl-coenzyme A carboxylase in rat epididymal adipose tissue. Inactivation of the enzyme is associated with phosphorylation and can be reversed on dephosphorylation, Biochem. J. 184, 23-32 (1979).
68. K-H. LEE and K-H. KIM, Stimulation by epinephrine of in vivo phosphorylation and inactivation of acetyl coenzyme A carboxylase of rat epididymal adipose tissue, J. Biol. Chem. 254, 1450-1453 (1979).
69. A. T. R. SIM and D. G. HARDIE, The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase, FEBS Letters 233, 294-298 (1988).
70. T. A. J. HAYSTEAD, F. MOORE, P. COHEN and D. G. HARDIE, Roles of the AMP-activated and cyclic-AMP-dependent protein kinases in the adrenaline-induced inactivation of acetyl-CoA carboxylase in rat adipocytes, Eur. J. Biochem. 187, 199-205 (1990).
71. S. P. DAVIES, S. A. HAWLEY, A. WOODS, D. CARLING, T. A. J. HAYSTEAD and D. G. HARDIE, Purification of the AMP-activated protein kinase on ATP-γ-Sepharose and analysis of its subunit structure, Eur. J. Biochem. 223, 351-357 (1994).
72. D. CARLING, K. AGUAN, A. WOODS, A. J. M. VERHOEVEN, R. K. BERI, C. H. BRENNAN, C. SIDEBOTTOM, M. D. DAVISON and J. SCOTT, Mammalian AMP-activated protein kinase is homologous to yeast and plant protein kinases involved in the regulation of carbon metabolism, J. Biol. Chem. 269, 11442-11448 (1994).
73. A. WOODS, P. C. F. CHEUNG, F. C. SMITH, M. D. DAVISON, J. SCOTT, R. K. BERI and D. CARLING, Characterization of AMP-activated protein kinase β and γ subunits. Assembly of the heterotrimeric complex in vitro, J. Biol. Chem. 271, 10282-10290 (1996).
74. D. STAPLETON, K. J. MITCHELHILL, G. GAO, J. WIDMER, B. J. MICHELL, T. TEH, C. M. HOUSE, C. S. FERNANDEZ, T. COX, L. A. WITTERS and B. E. KEMP, Mammalian AMP-activated protein kinase subfamily, J. Biol. Chem. 271, 611-614 (1996).
75. A. WOODS, M. R. MUNDAY, J. SCOTT, X. YANG, M. CARLSON and D. CARLING, Yeast SNF1 is functionally related to mammalian AMP-activated protein kinase and regulates acetyl-CoA carboxylase in vivo, J. Biol. Chem. 269, 19509-19515 (1994).
76. D. G. HARDIE and D. CARLING, The AMP-activated protein kinase. Fuel gauge of the mammalian cell?, Eur. J. Biochem. 246, 259-273 (1997).
77. D. CARLING, P. R. CLARKE, V. A. ZAMMIT and D. G. HARDIE, Purification and characterisation of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities, Eur. J. Biochem. 186, 129-136 (1989).
78. D. CARLING, V. A. ZAMMIT and D. G. HARDIE, A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis, FEBS Letters 223, 217-222 (1987).
79. 2+/calmodulin activates the calmodulin-dependent protein kinase I cascade via three independent mechanisms, J. Biol. Chem. 270, 27186-27190 (1995).
80. F. MOORE, J. WEEKES and D. G. HARDIE, Evidence that AMP triggers phosphorylation as well as allosteric activation of rat liver AMP-activated protein kinase, Eur. J. Biochem. 199, 691-697 (1991).
81. S. P. DAVIES, N. R. HELPS, P. T. W. COHEN and D. G. HARDIE, 5′-AMP inhibits dephosphorylation as well as promoting phosphorylation of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2Cα and native bovine protein phosphatase-2Ac, FEBS Letters 377, 421-425 (1995).
82. S. A. HAWLEY, M. D. DAVISON, A. WOODS, S. P. DAVIES, R. K. BERI, D. CARLING and D. G. HARDIE, Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase, J. Biol. Chem. 271, 27879-27887 (1996).
83. J. M. CORTON, J. G. GILLESPIE and D. G. HARDIE, Role of the AMP-activated protein kinase in the cellular stress response, Current Biology 4, 315-324 (1994).
84. J. E. SULLIVAN, K. J. BROCKLEHURST, A. E. MARLEY, F. CAREY, D. CARLING and R. K. BERI, Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase, FEBS Letters 353, 33-36 (1994).
85. N. HENIN, M-F. VINCENT, H. E. GRUBER and G. VAN DEN BERGHE, Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase, FASEB J. 9, 541-546 (1995).
86. D. G. HARDIE, Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase, Biochim. Biophys. Acta 1123, 231-238 (1992).
87. D. L. BRAUTIGAN, Phosphatases as partners in signalling networks, Advances in Second Messenger and Phosphoprotein Res. 31, 113-124 (1997).
88. L. A. WITTERS and B. E. KEMP, Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of 5′-AMP-activated protein kinase, J. Biol. Chem. 267, 2864-2867 (1992).
89. L. A. WITTERS, T. D. WATTS, D. L. DANIELS and J. EVANS, Insulin stimulates the dephosphorylation and activation of acetyl-CoA carboxylase, Proc. Natl. Acad. Sci. USA 85, 5473-5477 (1988).
90. R. HOLLAND and D. G. HARDIE, Both insulin and epidermal growth factor stimulate fatty acid synthesis and increase phosphorylation of acetyl-CoA carboxylase and ATP-citrate lyase in isolated hepatocytes, FEBS Letters 181, 308-312 (1985).
91. R. W. BROWNSEY and R. M. DENTON, Evidence that insulin activates fat-cell acetyl-CoA carboxylase by increased phosphorylation at a specific site, Biochem. J. 202, 77-86 (1982).
92. T. A. J. HAYSTEAD and D. G. HARDIE, Evidence that activation of acetyl-CoA carboxylase by insulin in adipocytes is mediated by a low-Mr effector and not by increased phosphorylation, Biochem. J. 240, 99-106 (1986).
93. K. J. HEESOM, S. K. MOULE and R. M. DENTON, Purification and characterisation of an insulin-stimulated protein-serine kinase which phosphorylates acetyl-CoA carboxylase, FEBS Letters 422, 43-46 (1998).
94. J. SOMMERCORN, J. A. MULLIGAN, F. J. LOZEMAN and E. G. KREBS, Activation of casein kinase II in response to insulin and epidermal growth factor, Proc. Natl. Acad. Sci. USA 84, 8834-8838 (1987).
95. J. SOMMERCORN, S. J. MCNALL, E. H. FISCHER and E. G. KREBS, Phosphorylation of acetyl-CoA carboxylase by casein kinase II enhances the rate of dephosphorylation of the cAMP-dependent protein kinase site, Fed. Proc. 46, 2003 (1987).
96. G. R. KRAKOWER and K-H. KIM, Effect of insulin on association of acetyl-CoA carboxylase phosphatase and acetyl-CoA carboxylase, Biochem. Biophys. Res. Commun. 130, 814-829 (1985).
97. W. W. WINDER, H. A. WILSON, D. G. HARDIE, B. B. RASMUSSEN, C. A. HUTBER, G. B. CALL, R. D. CLAYTON, L. M. CONLEY, S. YOON and B. ZHOU, Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A, J. Appl. Physiol. 82, 219-225 (1997).
98. W. W. WINDER and D. G. HARDIE, Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise, Am. J. Physiol. 270, E299-E304 (1996).
99. A. J. M. VERHOEVEN, A. WOODS, C. H. BRENNAN, S. HAWLEY, D. G. HARDIE, J. SCOTT, R. K. BERI and D. CARLING, The AMP-activated protein kinase gene is highly expressed in rat skeletal muscle. Alternative splicing and tissue distribution of the mRNA, Eur. J. Biochem. 228, 236-243 (1995).
100. M. M. AWAN and E. D. SAGGERSON, Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation, Biochem. J. 295, 61-66 (1993).
101. M. SADDIK, J. GAMBLE, L. A. WITTERS and G. D. LOPASCHUK, Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart, J. Biol. Chem. 268, 25836-25845 (1993).
102. N. KUDO, A. J. BARR, R. L. BARR, S. DESAI and G. D. LOPASCHUK, High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase, J. Biol. Chem. 270, 17513-17520 (1995).
103. N. KUDO, J. G. GILLESPIE, L. KING, L. A. WITTERS, R. SCHULZ, A. S. CLANACHAN and G. D. LOPASCHUK, Characterisation of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia, Biochim. Biophys. Acta 1301, 67-75 (1996).
104. C. A. HUTBER, D. G. HARDIE and W. W. WINDER, Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase, Am. J. Physiol. 272, E262-E266 (1997).
105. D. VAVVAS, A. APAZIDIS, A. K. SAHA, J. GAMBLE, A. PATEL, B. E. KEMP, L. A. WITTERS and N. B. RUDERMAN, Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated protein kinase in skeletal muscle, J. Biol. Chem. 272, 13255-13261 (1997).
106. M. PONTICOS, Q. L. LU, J. E. MORGAN, D. G. HARDIE, T. A. PARTRIDGE and D. CARLING, Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle, EMBO J. 17, 1688-1699 (1998).
107. W. W. WINDER, P. S. MACLEAN, J. C. LUCAS, J. E. FERNLEY and G. E. TRUMBLE, Effect of fasting and refeeding on acetyl-CoA carboxylase in rat hindlimb muscle, J. Appl. Physiol. 78, 578-582 (1995).
108. A. K. SAHA, D. VAVVAS, T. G. KUROWSKI, A. APAZIDIS, L. A. WITTERS, E. SHAFRIR and N. B. RUDERMAN, Malonyl-CoA regulation in skeletal muscle: Its link to cell citrate and the glucose-fatty acid cycle, Am. J. Phys. Endo. and Metab. 35, E641-E648 (1997).
109. P. O'CONNOR, J. FEELY and J. SHEPHERD, Lipid lowering drugs, British Medical Journal 300, 667-672 (1990).
110. P. A. TODD and A. WARD, Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia, Drugs 36, 314-339 (1988).
111. Y. A. KESANIEMI and S. M. GRUNDY, Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man, JAMA 251, 2241-2246 (1984).
112. H. M. FRICK, O. ELO, K. HAAPA, O. P. HEINONEN, P. HEINSALMI, P. HELO, J. K. HUTTUNEN, P. KAITANIEMI, P. KOSKINEN, V. MANNINEN, H. MAENPAA, M. MALKONEN, M. MANTTARI, S. NOROLA, A. PASTERNACK, J. PIKKARAINEN, M. ROMO, T. SJOBLOM and E. A. NIKKILA, Helsinki heart study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidaemia, N. Engl. J. Med. 317, 1237-1245 (1987).
113. G. SCHONFELD, The effects of fibrates on lipoprotein and hemostatic coronary risk factors, Atherosclerosis 111, 161-174 (1994).
114. K. SAKU, P. S. GARTSIDE, B. A. HYND and M. L. KASHYAP, Mechanism of action of gemfibrozil on lipoprotein metabolism, J. Clin. Invest. 75, 1702-1712 (1985).
115. N. VU-DAC, K. SCHOONJANS, V. KOSYKH, J. DALLONGEVILLE, J-C. FRUCHART, B. STAELS and J. AUWERX, Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor, J. Clin. Invest. 96, 741-750 (1995).
116. M. J. CASLAKE, C. J. PACKARD, A. GAW, E. MURRAY, B. A. GRIFFIN, B. D. VALLANCE and J. SHEPHERD, Fenofibrate and LDL metabolic heterogeneity in hypercholesterolaemia, Arterioscler. Thromb. 13, 702-711 (1993).
117. C. DACHET, E. CAVALLEROLE, C. MARTIN, G. GIRARDOT and B. JACOTOT, Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridaemic patients, Atherosclerosis 113, 1-9 (1995).
118. K. SCHOONJANS, J. PEINADO-ONSURBE, A-M. LEFEBVRE, R. A. HEYMAN, M. BRIGGS, S. DEEB, B. STAELS and J. AUWERX, PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene, EMBO J. 15, 5336-5348 (1996).
119. B. STAELS, N. VU-DAC, V. KOSYKH, R. SALADIN, J. C. FRUCHART, J. DALLONGEVILLE and J. AUWERX, Fibrates down-regulate apolipoprotein C-III expression independent of induction of peroxisomal acyl Co-enzyme A oxidase, J. Clin. Invest. 95, 705-712 (1995).
120. S. E. HAHN and D. M. GOLDBERG, Modulation of lipoprotein production in HEP G2 cells by fenofibrate and clofibrate, Biochem. Pharmacol. 43, 625-633 (1992).
121. P. ZIMETBAUM, W. H. FRISHMAN and S. KAHN, Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins, J. Clin. Pharmacol. 31, 25-27 (1991).
122. P. B. LAZAROW and C. DE DUVE, A fatty acyl-CoA oxidising system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidaemic drug, Proc. Natl. Acad. Sci. USA 73, 2043-2046 (1976).
123. G. P. MANNAERTS, L. J. DEBEER, J. THOMAS and P. J. DE SCHEPPER, Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats, J. Biol. Chem. 254, 4585-4595 (1979).
124. R. J. KAIKAUS, W. K. CHAN, N. LYSENKO, R. RAY, ORTIZ DE MONTELLANO and N. M. BASS, Induction of peroxisomal fatty acid β-oxidation and liver fatty acid-binding protein by peroxisome proliferators, J. Biol. Chem. 268, 9593-9603 (1993).
125. M. ALEGRET, R. FERRANDO, M. VAZQUEZ, T. ADZET, M. MERLOS and J. C. LAGUNA, Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates, Brit. J. Pharmacol. 112, 551-556 (1994).
126. T. OSUMI, J. K. WEN and T. HASHIMOTO, Two cis-acting regulatory elements in the peroxisome proliferator-response element enhancer region of rat acyl-CoA oxidase gene, Biochem. Biophys. Res. Commun. 175, 866-871 (1991).
127. A. S. MUERHOFF, K. J. GRIFFIN and E. F. JOHNSON, The peroxisome proliferator activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid ω-hydroxylase, by clofibric acid, J. Biol. Chem. 267, 19051-19053 (1992).
128. M. T. KAHONEN and R. H. YLIKAHRI, Effect of clofibrate and gemfibrozil on the activities of mitochondrial carnitine acyltransferases in rat liver, Atherosclerosis 32, 47-56 (1979).
129. B. MITTAL and C. K. R. KURUP, Induction of carnitine acetyltransferase by clofibrate in rat liver, Biochem. J. 194, 249-255 (1981).
130. F. HASHIMOTO, T. ISHIKAWA, S. HAMADA and H. HAYASHI, Effect of gemfibrozil on lipid biosynthesis from acetyl-CoA derived from peroxisomal β-oxidation, Biochem. Pharmacol. 49, 1213-1221 (1995).
131. P. GERONDAES, K. G. M. M. ALBERTI and L. AGIUS, Fatty acid metabolism in hepatocytes cultured with hypolipidaemic drugs, Biochem. J. 253, 161-167 (1988).
132. P. SCHWANDT, Fibrates and triglyceride metabolism, Eur. J. Clin. Pharmacol. 40, S41-S43 (1991).
133. B. I. COHEN, R. F. RAICHT, S. SHEFER and E. H. MOSBACH, Effects of clofibrate on sterol metabolism in the rat, Biochim. Biophys. Acta 369, 79-85 (1974).
134. B. HAUGHOM and O. SPYDEVOLD, The mechanism underlying the hypolipidaemic effect of perflurooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid, Biochim. Biophys. Acta 1128, 65-72 (1992).
135. D. R. AVOY, E. A. SWYRYD and R. G. GOULD, Effects of α-ρ-chlorophenoxyisobutyryl ethyl ester (CPIB) with and without androsterone on cholesterol biosynthesis in rat liver, J. Lipid Res. 6, 369-376 (1965).
136. L. WHITE, Regulation of hepatic cholesterol biosynthesis by clofibrate administration, J. Pharmacol. Exp. Therap. 178, 361-370 (1971).
137. D. ZAKIM, R. S. PARADINI and R. H. HERMAN, Effect of clofibrate (ethyl-chlorophenoxyisobutyrate) feeding on glycolytic and lipogenic enzymes and hepatic glycogen synthesis in the rat, Biochem. Pharmacol. 19, 305-310 (1970).
138. M. E. MARAGOUDAKIS and H. HANKIN, On the mode of action of lipid-lowering agents, J. Biol. Chem. 246, 348-358 (1971).
139. R. M. SANCHEZ, M. VAZQUEZ, M. ALEGRET, M. VINALS, T. ADZET, M. MERLOS and J. C. LAGUNA, Cytosolic lipogenic enzymes: effect of fibric acid derivatives in vitro, Life Sciences 52, 213-222 (1993).
140. M. CASTILLO, C. BURGOS, F. RODRIGUEZ-VICO, M. F. ZAFRA and E. GARCIA-PEREGRIN, Effects of clofibrate on the main regulatory enzymes of cholesterogenesis, Life Sciences 46, 397-403 (1990).
141. C. BOCOS, M. CASTRO, G. QUACK and E. HERRERA, Studies with etofibrate in the rat. Part II: a comparison of the effects of prolonged and acute administration on plasma lipids, liver enzymes and adipose tissue lipolysis, Biochim. Biophys. Acta 1168, 340-347 (1993).
142. K. SCHOONJANS, B. STAELS and J. AUWERX, Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of the fibrates and fatty acids on gene expression, J. Lipid Res. 37, 907-925 (1996).
143. B. STAELS and J. AUWERX, Role of PPAR in the phamacological regulation of lipoprotein metabolism by fibrates and thiazolidinediones, Curr. Pharmaceut. Design 3, 1-14 (1996).
144. C. J. HEMINGWAY, K. K. TEY and M. R. MUNDAY, Short-term inhibition of fatty acid and cholesterol biosynthesis by the lipid-lowering drug gemfibrozil in primary rat hepatocyte cultures and rat liver in vivo, Biochem. Soc. Trans. 23, 496 (1995).
145. C. J. HEMINGWAY, K. K. TEY and M. R. MUNDAY, Short-term inhibition of hepatic fatty acid and cholesterol synthesis by the hypolipidaemic drug gemfibrozil. Activation of the AMP-activated protein kinase cascade, submitted to Biochem. J. in press (1999).
146. M. E. MARAGOUDAKIS, On the mode of action of lipid-lowering agents, J. Biol. Chem. 245, 4136-4140 (1970).
147. A. M. B. MOIR and V. A. ZAMMIT, Changes in the properties of cytosolic acetyl-CoA carboxylase studied in cold-clamped liver samples from fed, starved and starvedrefed rats, Biochem. J. 272, 511-517 (1990).
148. C. J. HEMINGWAY and M. R. MUNDAY, Gemfibrozil activation of AMP-activated protein kinase, Biochem. Soc. Trans. 25, S676 (1997).
149. M. BRONFMAN, M. N. MORALES, L. AMIGO, A. ORELLANA, L. NUNEZ, L. CARDENAS and P. C. HIDALGO, Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes, Biochem. J. 284, 289-295 (1992).
150. J. C. LAMB, R. G. KOCH and S. R. BUSH, An enzymatic explanation of the differential effects of oleate and gemfibrozil on cultured hepatocyte triacylglycerol and phosphatidylcholine biosynthesis and secretion, Biochim. Biophys. Acta 1165, 299-305 (1993).
151. J. D. MCGARRY and D. W. FOSTER, Regulation of hepatic fatty acid oxidation and ketone body production, Ann. Rev. Biochem. 49, 395-420 (1980).
152. J. C. RODRIGUEZ, G. GIL-GOMEZ, F. C. HEGARDT and D. HARO, Peroxisome proliferator activated receptor mediates the induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids, J. Biol. Chem. 269, 18767-18772 (1994).
153. A. M. B. MOIR, B-S. PARK and V. A. ZAMMIT, Quantification in vivo of the effects of different types of dietary fat on the loci of control involved in hepatic triacylglycerol secretion, Biochem. J. 308, 537-542 (1995).
154. E. PANEK, G. A. COOK and N. W. CORNELL, Inhibition by 5-(tetradecyloxy)-2-furoic acid of fatty acid and cholesterol synthesis in isolated rat hepatocytes, Lipids 12, 814-818 (1977).
155. S. A. MCCUNE and R. A. HARRIS, Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis, J. Biol. Chem. 254, 10095-10101 (1979).
156. C. M. ARBEENY, D. S. MEYERS, K. E. BERGQUIST and R. E. GREGG, Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster, J. Lipid Res. 33, 843-851 (1992).
157. D. H. WILLIAMSON, J. MELLANBY and H. A. KREBS, Enzymic determination of (D-)-β-hydroxybutyric acid and acetoacetic acid in blood, Biochem. J. 82, 90-96 (1962).
158. G. F. GIBBONS, Assembly and secretion of hepatic very-low-density lipoprotein, Biochem. J. 268, 1-13 (1990).